Premium
Rapidly growing non‐tuberculous mycobacterial infection in a renal transplant patient after alemtuzumab induction
Author(s) -
Hazara A.M.,
Edey M.,
Roy A.,
Bhandari S.
Publication year - 2014
Publication title -
transplant infectious disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.69
H-Index - 67
eISSN - 1399-3062
pISSN - 1398-2273
DOI - 10.1111/tid.12269
Subject(s) - alemtuzumab , medicine , renal transplant , immunology , mycobacterium chelonae , population , transplantation , tuberculosis , mycobacterium , pathology , environmental health
Renal transplant recipients are at high risk of developing opportunistic infections particularly in the first 6 months after transplantation. Organisms causing such infections include rapidly growing non‐tuberculous mycobacteria ( NTM ). Lymphocytes have a central role in combating mycobacterial infections. The use of lymphocyte‐depleting agents, such as alemtuzumab, in the renal transplant population has increased in recent years. A case of multifocal osteomyelitis caused by one of the NTM , M ycobacterium chelonae , in a renal transplant recipient, after alemtuzumab induction, is presented.